Defibrotide for the treatment of veno-occlusive disease after liver transplantation

Keyphrases

• Liver Transplantation 100%
• Venous Disease 100%
• Defibrotide 100%
• Total Bilirubin 28%
• Stenosis 14%
• Weight Gain 14%
• Escherichia Coli 14%
• Disease Stage 14%
• Transplantation 14%
• Sepsis 14%
• Poor Outcome 14%
• Ascites 14%
• Thrombolytic Agents 14%
• Hepatitis C 14%
• Antithrombotic Agents 14%
• Multiple Organ Failure 14%
• Promising Drug 14%
• Clinical Resolution 14%
• Venules 14%
• Hepatitis B Infection 14%
• Coagulopathy 14%
• Jaundice 14%
• Immunosuppressive Regimens 14%
• Acute Rejection 14%
• Acute Cellular Rejection 14%
• Orthotopic Liver Transplantation 14%
• Anticoagulant Effect 14%
• Systemic Anticoagulation 14%
• Coagulopathic 14%
• Antithrombotic Property 14%
• Centrilobular Necrosis 14%
• Polydeoxyribonucleotide 14%

Medicine and Dentistry

• Liver Transplantation 100%
• Vein Occlusion 100%
• Defibrotide 100%
• Antithrombotic 42%
• Bilirubin 28%
• Thrombolytic Drug 28%
• Acute Graft Rejection 28%
• Prospective Study 14%
• Stenosis 14%
• Infection 14%
• Escherichia coli 14%
• Sepsis 14%
• Side Effect 14%
• Ascites 14%
• Necrosis 14%
• Hepatitis C 14%
• Immunosuppressive Drug 14%
• Multiple Organ Dysfunction Syndrome 14%
• Hepatitis B 14%
• Venule 14%
• Jaundice 14%
• Azathioprine 14%
• Coagulopathy 14%
• Polydeoxyribonucleotide 14%
• Diseases 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Vein Occlusion 100%
• Defibrotide 100%
• Anticoagulant Agent 42%
• Fibrinolytic Agent 28%
• Bilirubin 28%
• Acute Graft Rejection 28%
• Side Effect 14%
• Stenosis 14%
• Infection 14%
• Escherichia coli 14%
• Prospective Study 14%
• Sepsis 14%
• Necrosis 14%
• Hepatitis C 14%
• Immunosuppressive Agent 14%
• Hepatitis B 14%
• Ascites 14%
• Azathioprine 14%
• Blood Clotting Disorder 14%
• Jaundice 14%
• Multiple Organ Failure 14%
• Polydeoxyribonucleotide 14%
• Diseases 14%